The Oncology Institute, Inc. (TOI)
TOI Stock Price Chart
Explore The Oncology Institute, Inc. interactive price chart. Choose custom timeframes to analyze TOI price movements and trends.
TOI Company Profile
Discover essential business fundamentals and corporate details for The Oncology Institute, Inc. (TOI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Care Facilities
IPO Date
4 Jun 2020
Employees
825.00
Website
https://theoncologyinstitute.comCEO
Daniel Virnich FACHE,
Description
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
TOI Financial Timeline
Browse a chronological timeline of The Oncology Institute, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 12 Nov 2025
EPS estimate is -$0.12, while revenue estimate is $122.63M.
Earnings released on 13 Aug 2025
EPS came in at -$0.14 matching the estimated -$0.14, while revenue for the quarter reached $119.80M , missing expectations by -2.24%.
Earnings released on 14 May 2025
EPS came in at -$0.17 , while revenue for the quarter reached $104.41M .
Earnings released on 24 Mar 2025
EPS came in at -$0.14 falling short of the estimated -$0.08 by -75.00%, while revenue for the quarter reached $100.27M , missing expectations by -8.14%.
Earnings released on 13 Nov 2024
EPS came in at -$0.18 falling short of the estimated -$0.07 by -157.14%, while revenue for the quarter reached $99.90M , missing expectations by -7.11%.
Earnings released on 13 Aug 2024
EPS came in at -$0.17 falling short of the estimated -$0.10 by -70.00%, while revenue for the quarter reached $98.58M , missing expectations by -4.58%.
Earnings released on 14 May 2024
EPS came in at -$0.22 falling short of the estimated -$0.12 by -83.33%, while revenue for the quarter reached $94.67M , missing expectations by -0.52%.
Earnings released on 27 Mar 2024
EPS came in at -$0.21 falling short of the estimated -$0.11 by -90.91%, while revenue for the quarter reached $85.79M , beating expectations by +4.57%.
Earnings released on 8 Nov 2023
EPS came in at -$0.19 falling short of the estimated -$0.13 by -46.15%, while revenue for the quarter reached $82.04M , missing expectations by -0.01%.
Earnings released on 8 Aug 2023
EPS came in at -$0.19 falling short of the estimated -$0.17 by -11.76%, while revenue for the quarter reached $80.22M , beating expectations by +5.29%.
Earnings released on 10 May 2023
EPS came in at -$0.10 surpassing the estimated -$0.17 by +41.18%, while revenue for the quarter reached $76.19M , beating expectations by +17.22%.
Earnings released on 9 Mar 2023
EPS came in at -$0.16 surpassing the estimated -$0.18 by +11.11%, while revenue for the quarter reached $71.42M , beating expectations by +10.31%.
Earnings released on 9 Nov 2022
EPS came in at -$0.17 falling short of the estimated -$0.16 by -6.25%, while revenue for the quarter reached $64.98M , missing expectations by -5.77%.
Earnings released on 9 Aug 2022
EPS came in at -$0.06 , while revenue for the quarter reached $60.92M .
Earnings released on 11 May 2022
EPS came in at -$0.29 , while revenue for the quarter reached $55.16M .
Earnings released on 11 Mar 2022
EPS came in at -$0.15 , while revenue for the quarter reached $52.30M .
Earnings released on 10 Mar 2022
EPS came in at $0.26 , while revenue for the quarter reached $52.28M .
Earnings released on 16 Aug 2021
EPS came in at $0.05 , while revenue for the quarter reached $49.84M .
Earnings released on 28 May 2021
EPS came in at -$0.02 , while revenue for the quarter reached $48.58M .
Earnings released on 30 Mar 2021
EPS came in at -$0.30 , while revenue for the quarter reached $187.51M .
Earnings released on 13 Nov 2020
EPS came in at -$0.08 , while revenue for the quarter reached $47.25M .
TOI Stock Performance
Access detailed TOI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.